Clinical Trial Update: Almonertinib Therapy in Patients With Abnormal Liver Function After EGFR-TKI Treatment, or Almonertinib First-line Therapy in Patients With Basic Hepatopathy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating almonertinib in non-small cell lung cancer patients with abnormal liver function after EGFR-TKI treatment or as first-line therapy i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Almonertinib (almonertinib)

Snippet

Sponsor: West China Hospital | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN